Sandra D. Bohling

795 total citations
22 papers, 586 citations indexed

About

Sandra D. Bohling is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Sandra D. Bohling has authored 22 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Sandra D. Bohling's work include Lymphoma Diagnosis and Treatment (9 papers), CAR-T cell therapy research (4 papers) and Cutaneous lymphoproliferative disorders research (4 papers). Sandra D. Bohling is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), CAR-T cell therapy research (4 papers) and Cutaneous lymphoproliferative disorders research (4 papers). Sandra D. Bohling collaborates with scholars based in United States, Israel and Canada. Sandra D. Bohling's co-authors include Kojo S.J. Elenitoba‐Johnson, Kimberly H. Allison, Ryan S. Robetorye, Thomas C. King, Megan S. Lim, Carl T. Wittwer, Stephen D. Jenson, Zhaosheng Lin, Michael S. Brown and Sherrie L. Perkins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and FEBS Letters.

In The Last Decade

Sandra D. Bohling

20 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra D. Bohling United States 13 211 209 208 141 89 22 586
Yoshihiro Nozawa Japan 15 176 0.8× 250 1.2× 190 0.9× 227 1.6× 65 0.7× 62 644
Paola Zancai Italy 13 269 1.3× 242 1.2× 217 1.0× 89 0.6× 69 0.8× 18 516
Tao Ouyang China 8 157 0.7× 260 1.2× 196 0.9× 64 0.5× 55 0.6× 12 487
Paul Glover United States 13 230 1.1× 250 1.2× 264 1.3× 95 0.7× 161 1.8× 17 634
Rachel Swart United States 9 353 1.7× 191 0.9× 194 0.9× 202 1.4× 42 0.5× 11 671
Karin Orscheschek Germany 7 188 0.9× 114 0.5× 231 1.1× 203 1.4× 74 0.8× 8 503
Lippman Sm United States 9 221 1.0× 346 1.7× 327 1.6× 165 1.2× 125 1.4× 16 807
Hans G. Drexler Germany 9 154 0.7× 180 0.9× 150 0.7× 150 1.1× 92 1.0× 11 485
Joyce Setsuda United States 10 297 1.4× 177 0.8× 216 1.0× 290 2.1× 22 0.2× 11 658
Tatsuo Abe Japan 14 119 0.6× 339 1.6× 89 0.4× 152 1.1× 72 0.8× 26 660

Countries citing papers authored by Sandra D. Bohling

Since Specialization
Citations

This map shows the geographic impact of Sandra D. Bohling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra D. Bohling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra D. Bohling more than expected).

Fields of papers citing papers by Sandra D. Bohling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra D. Bohling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra D. Bohling. The network helps show where Sandra D. Bohling may publish in the future.

Co-authorship network of co-authors of Sandra D. Bohling

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra D. Bohling. A scholar is included among the top collaborators of Sandra D. Bohling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra D. Bohling. Sandra D. Bohling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lamble, Adam J., Sandra D. Bohling, Kara L. Davis, et al.. (2025). Harmonization on defining B‐cell recovery post CD19‐CAR T‐cell therapy in B‐cell acute lymphoblastic leukemia: An international consensus statement. HemaSphere. 9(11). e70247–e70247.
2.
Chisholm, Karen M. & Sandra D. Bohling. (2023). Childhood Myelodysplastic Syndrome. Clinics in Laboratory Medicine. 43(4). 639–655. 3 indexed citations
3.
Summers, Corinne, Karen M. Chisholm, Sandra D. Bohling, et al.. (2023). Plasticity of lineage switch in B-ALL allows for successful rechallenge with CD19-directed immunotherapy. Blood Advances. 7(12). 2825–2830. 4 indexed citations
4.
Rudzinski, Erin R., Sandra D. Bohling, Yajuan J. Liu, et al.. (2023). CD43-positive, EWSR1::FLI1-rearranged Soft Tissue Sarcoma in a Pediatric Patient With History of B-Cell Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 45(5). e635–e638. 1 indexed citations
5.
Chisholm, Karen M., Sandra D. Bohling, Karen D. Tsuchiya, & Vera Paulson. (2022). A Malignant Mimicker: Features of Kikuchi-Fujimoto Disease in the Pediatric Population. Pediatric and Developmental Pathology. 25(5). 538–547. 3 indexed citations
6.
Bohling, Sandra D., et al.. (2015). Flow cytometric analysis of CD200 expression by pulmonary small cell carcinoma. Cytometry Part B Clinical Cytometry. 90(6). 493–498. 7 indexed citations
7.
Bohling, Sandra D., et al.. (2012). Comparison of Clot-Based vs Chromogenic Factor Xa Procoagulant Phospholipid Activity Assays. American Journal of Clinical Pathology. 137(2). 185–192. 12 indexed citations
8.
Jordan, C. Diana, Sandra D. Bohling, Noé L. Charbonneau, & Lynn Y. Sakai. (2010). Fibrillins in Adult Human Ovary and Polycystic Ovary Syndrome: Is Fibrillin-3 Affected in PCOS?. Journal of Histochemistry & Cytochemistry. 58(10). 903–915. 38 indexed citations
9.
Bohling, Sandra D. & Kimberly H. Allison. (2008). Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target. Modern Pathology. 21(12). 1527–1532. 118 indexed citations
10.
Bohling, Sandra D., Stephen D. Jenson, David K. Crockett, et al.. (2007). Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma. Leukemia Research. 32(3). 383–393. 14 indexed citations
11.
Frost, Michael, James Newell, Sandra D. Bohling, et al.. (2003). BCL-2 Is Consistently Expressed in Hyperplastic Marginal Zones of the Spleen, Abdominal Lymph Nodes, and Ileal Lymphoid Tissue. The American Journal of Surgical Pathology. 27(7). 888–894. 14 indexed citations
12.
Elenitoba‐Johnson, Kojo S.J., Stephen D. Jenson, Robert Palais, et al.. (2003). Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proceedings of the National Academy of Sciences. 100(12). 7259–7264. 140 indexed citations
13.
Robetorye, Ryan S., Sandra D. Bohling, James P. Morgan, et al.. (2002). Microarray Analysis of B-Cell Lymphoma Cell Lines with the t(14;18). Journal of Molecular Diagnostics. 4(3). 123–136. 22 indexed citations
14.
Fillmore, Gary Chris, Zhaosheng Lin, Sandra D. Bohling, et al.. (2002). Gene expression profiling of cell lines derived from T‐cell malignancies. FEBS Letters. 522(1-3). 183–188. 17 indexed citations
15.
Elenitoba‐Johnson, Kojo S.J., et al.. (2002). Fluorescence PCR Quantification of Cyclin D1 Expression. Journal of Molecular Diagnostics. 4(2). 90–96. 14 indexed citations
16.
Elenitoba‐Johnson, Kojo S.J. & Sandra D. Bohling. (2001). Solution-Based Scanning for Single-Base Alterations Using a Double-Stranded DNA Binding Dye and Fluorescence-Melting Profiles. American Journal Of Pathology. 159(3). 845–853. 10 indexed citations
17.
Elenitoba‐Johnson, Kojo S.J., Sandra D. Bohling, Carl T. Wittwer, & Thomas C. King. (2001). Multiplex PCR by multicolor fluorimetry and fluorescence melting curve analysis. Nature Medicine. 7(2). 249–253. 62 indexed citations
18.
Robetorye, Ryan S., Sandra D. Bohling, L. Jeffrey Medeiros, & Kojo S.J. Elenitoba‐Johnson. (2000). Follicular Lymphoma with Monocytoid B-Cell Proliferation: Molecular Assessment of the Clonal Relationship between the Follicular and Monocytoid B-Cell Components. Laboratory Investigation. 80(10). 1593–1599. 19 indexed citations
19.
Elenitoba‐Johnson, Kojo S.J., et al.. (2000). PCR Analysis of the Immunoglobulin Heavy Chain Gene in Polyclonal Processes Can Yield Pseudoclonal Bands as an Artifact of Low B Cell Number. Journal of Molecular Diagnostics. 2(2). 92–96. 65 indexed citations
20.
Bohling, Sandra D., Carl T. Wittwer, Thomas C. King, & Kojo S.J. Elenitoba‐Johnson. (1999). Fluorescence melting curve analysis for the detection of the bcl-1/JH translocation in mantle cell lymphoma.. PubMed. 79(3). 337–45. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026